Alerts will be sent to your verified email
Verify Email
ANG
|
ANG Lifesciences
|
Omkar Pharmachem
|
Deccan Health Care
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
12.03 % | 2.2 % | 0.79 % |
|
5yr average Equity Multiplier
|
3.3 | 1.05 | 1.17 |
|
5yr Average Asset Turnover Ratio
|
0.77 | 0.05 | 0.47 |
|
5yr Avg Net Profit Margin
|
-2.26 % | 44.95 % | 1.37 % |
|
Price to Book
|
0.49 | 3.15 | 0.25 |
|
P/E
|
0.0 | 350.0 | 11.85 |
|
5yr Avg Cash Conversion Cycle
|
70.26 Days | 49.27 Days | 218.27 Days |
|
Inventory Days
|
107.37 Days | 0.0 | 372.92 Days |
|
Days Receivable
|
274.82 Days | 49.27 Days | 54.52 Days |
|
Days Payable
|
235.98 Days | 0.0 | 94.94 Days |
|
5yr Average Interest Coverage Ratio
|
1.81 | 7.4 | 12.96 |
|
5yr Avg ROCE
|
15.08 % | 2.6 % | 2.08 % |
|
5yr Avg Operating Profit Margin
|
7.68 % | 44.39 % | 7.39 % |
|
5 yr average Debt to Equity
|
0.97 | 0.06 | 0.02 |
|
5yr CAGR Net Profit
|
n/a | -1.89 % | 24.36 % |
|
5yr Average Return on Assets
|
1.04 % | 2.09 % | 0.68 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
70.6 % | 0.03 % | 18.42 % |
|
Share Pledged by Promoters
|
44.88 % | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-0.55 % | 0.0 | -3.79 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
ANG Lifesciences
|
Omkar Pharmachem
|
Deccan Health Care
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|